Kate Law, Cancer Research UK's director of clinical research, added:
In general the outlook for leukaemia patients has improved dramatically in recent decades. But when leukaemia is diagnosed in older people its much harder to treat and there is a real need for effective treatments that are suitable for this age group.
Importantly this new trial shows that GO may have particular benefits for patients over 60, who may be unsuitable for other more intensive treatments. This is good news and we are now looking to see if these results can be replicated in younger patients.
More top news
Prison terms of less than a year do little to rehabilitate offenders.
According to the poll, conducted for The Irish Times, the country chose to liberalise its laws by 68% to 32%.
Harvey Weinstein, health and a plot to fix an England cricket match are on the front pages.